Key Metrics of Corcept Therapeutics
Revenue$482M▲ 20.0% YoYFY 2023
Operating income$107M▼ 4.8% YoY
Net profit$106M▲ 4.7% YoY
Shareholders' equity$507M
Market cap$9.3BCORT · $85.86
Competitors10identified
About Corcept Therapeutics
Sectors
Company details
- Website
- corcept.com
- Founded
- 2004
- Listed
- Nasdaq: CORT (since 2004)
Operational Areas of Corcept Therapeutics
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameCorcept Therapeutics Incorporated
TickerCORT
ExchangeNasdaq
CountryUnited States
SEC CIK0001088856
Listed since2004
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.corcept.com
US market & SEC filings
CORT · Nasdaq · SEC CIK 0001088856
Last price · 26 Oct 2026
$85.86
−20.13%
Market cap$9.3B
P/E91.3On FY 2023 diluted EPS
Volume3,098,963
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited StatesListed 2004
CORT share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeMenlo Park
GSTIN—
Email—
Websitehttp://www.corcept.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Corcept Therapeutics
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.